BIOL - バイオレ―ズ （Biolase Inc.） バイオレ―ズBIOLのチャート
BIOLの企業情報
| symbol | BIOL |
|---|---|
| 会社名 | Biolase Inc （バイオレ―ズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 バイオレーサー・テクノロジー(BIOLASE Technology Inc)は歯科用レーザー会社。同社は医療技術会社であり、歯科用レーザーの開発・製造・販売、及び技術中心型の歯科用イメージング機器と製品の流通・販売に従事する。同社のレーザー製品は疼痛の減少、回復時間の加速を実現できる技術を採用した。同社の製品は美容および外科アプリケーションを含む一連の歯科治療を行う歯科用レーザーシステム、及び一連の歯科用イメージング機器を含む。他の開発中の製品は眼科や他の医療およびコンシューマ市場を目当てにする。 バイオレ―ズは米国の歯科・医療機器メ―カ―。主要製品はレ―ザ―エネルギ―と水を組み合わせたレ―ザ―システムWaterLase(ウォ―タ―レ―ズ)。患者にとってより安全で痛みを軽減した治療法を提供。またレ―ザ―ホワイトニングと治療の為のEpicｈやワイヤレス歯科レ―ザ―iLase、動物用レ―ザ―Epic Vシリ―ズなども展開。 BIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA. |
| 本社所在地 | 4 Cromwell Irvine CA 92618 USA |
| 代表者氏名 | Jonathan T. Lord ジョナサン・T・ロード |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 949-361-1200 |
| 設立年月日 | 31809 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 195人 |
| url | www.biolase.com |
| nasdaq_url | https://www.nasdaq.com/symbol/biol |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -17.70500 |
| 終値（lastsale） | 1.53 |
| 時価総額（marketcap） | 31513258.53 |
| 時価総額 | 時価総額（百万ドル） 32.13117 |
| 売上高 | 売上高（百万ドル） 45.61400 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 29.31617 |
| 当期純利益 | 当期純利益（百万ドル） 2.71400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 BIOLASE Inc revenues decreased 6% to $22.2M. Net loss applicable to common stockholders decreased 20% to $9.9M. Revenues reflect United States segment decrease of 14% to $12.9M. Lower net loss reflects others decrease of 20% to $2.5M (expense) Sales and Marketing - Balancing value decrease of 3% to $8.3M (expense). |
BIOLのテクニカル分析
BIOLのニュース
BIOLASE Announces Launch On M-Vest 2020/10/27 12:30:00 PR Newswire
FOOTHILL RANCH, Calif., Oct. 27, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has made available an updated corporate presentation and business summary overview on M-Vest.com. The Company plans to provide regular updates…
Laser Therapy Market Is Expected To Reach US$ 3,514.02 Million By 2027 With Alma Lasers ,Coherent, Inc. ,biolitec Group ,BIOLASE, Inc. ,IPG Photonics Corporation ,Boston Scientific Corporation ,BTL 2020/10/23 10:09:06 OpenPR
Laser Therapy Market Is Expected To Reach US$ 3,514.02 Million By 2027 From US$ 1,665.65 Million In 2019; It Is Estimated To Grow At A CAGR Of 9.9% From 2020 To 2027. The key players profiled in the Laser Therapy Market
Contrasting Envista (NYSE:NVST) and BIOLASE (NYSE:BIOL) 2020/10/20 09:30:50 Dakota Financial News
Envista (NYSE:NVST) and BIOLASE (NASDAQ:BIOL) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Profitability This table compares Envista and BIOLASE’s net margins, return on equity and return on assets. Net Margins […]
BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth 2020/10/14 11:30:00 PR Newswire
FOOTHILL RANCH, Calif., Oct. 14, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for the third quarter ended September 30, 2020. The Company expects to report third quarter revenue in the range of…
BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis 2020/09/15 12:30:00 PR Newswire
FOOTHILL RANCH, Calif., Sept. 15, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hosted nearly 400 dental professionals last Thursday evening during a panel discussion on the NEW Journal of Periodontology landmark study from…
BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth 2020/10/14 11:30:00 PR Newswire
FOOTHILL RANCH, Calif., Oct. 14, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for the third quarter ended September 30, 2020. The Company expects to report third quarter revenue in the range of…
BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis 2020/09/15 12:30:00 PR Newswire
FOOTHILL RANCH, Calif., Sept. 15, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hosted nearly 400 dental professionals last Thursday evening during a panel discussion on the NEW Journal of Periodontology landmark study from…
Global Dental Lasers Market: COVID-19 Business Continuity Plan | Evolving Opportunities with A.R.C. Laser GmbH and BIOLASE Inc. | Technavio 2020/09/15 07:30:00 Business Wire
LONDON--(BUSINESS WIRE)-- #DentalLasersMarket--The Global Dental Lasers Market will grow by $ 190.10 mn during 2020-2024
BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference 2020/09/03 12:30:00 PR Newswire
FOOTHILL RANCH, Calif., Sept. 3, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an…
BIOLASE Reports Second Quarter 2020 Financial Results 2020/08/13 20:05:00 PR Newswire
FOOTHILL RANCH, Calif., Aug. 13, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2020 and provided a business update. "Despite the ongoing challenges associated with the…
BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference 2020/09/03 12:30:00 PR Newswire
FOOTHILL RANCH, Calif., Sept. 3, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an…
BIOLASE Reports Second Quarter 2020 Financial Results 2020/08/13 20:05:00 PR Newswire
FOOTHILL RANCH, Calif., Aug. 13, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2020 and provided a business update. "Despite the ongoing challenges associated with the…
BIOLASE Announces Closing Of Oversubscribed Rights Offering 2020/07/22 20:05:00 PR Newswire
IRVINE, Calif., July 22, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, further strengthened its balance sheet today as it closed the Company's previously announced rights offering (the "Offering"). At the closing, BIOLASE issued and sold an aggregate…
BIOLASE Announces Expiration Of Oversubscribed Rights Offering 2020/07/16 10:30:00 PR Newswire
IRVINE, Calif., July 16, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, announced today the expiration of the Company's rights offering, which was oversubscribed. The subscription period for its previously announced rights offering (the "Offering") of…
BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020 2020/07/09 10:30:00 PR Newswire
IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a panel discussion on Re-Engaging Medical Practices in an Era of COVID-19, presented by Maxim Group…